Member, Director of Development, Vaccine and Infectious Diseases Division
Affiliate Professor, Departments of Global Health and Epidemiology, University of Washington
Ann Duerr's research focuses on AIDS and HIV prevention, including novel vaccine strategies for induction of mucosal immunity, studies on antiretroviral therapy (ART), clinical trials in resource-poor settings and eludicating factors that help prevent sexual transmission of HIV. She has published widely on HIV infection in women, biological and epidemiological determinants of HIV transmission, and HIV-STD interactions. She has served on numerous advisory committees, both domestically and internationally, and worked extensively with the World Health Organization as a consultant.
Associate, Vaccine and Infectious Diseases Division
Acting Assistant Professor, Division of Allergy and Infectious Diseases University of Washington
Rachel Bender Ignacio, MD, MPH, conducts research focused on the role of co-infections and inflammation on HIV outcomes. She also collaborates on many studies on HIV-associated malignancies, specifically on cancers caused by human herpesviruses, and the role of antiretroviral therapy in treating HIV-associated cancers. She is board certified in Infectious Diseases and Internal Medicine, and feels privileged to be able to provide HIV primary care and serve as a consultant for the Infectious Disease service at Harborview Medical Center and for the Solid Organ Transplant ID service at the University of Washington Medical Center.
Dr. Bender Ignacio was recently elected to the Board of Directors of the HIV Medicine Association, the professional organization that represents the interests of HIV health care providers and researchers and their patients by promoting quality in HIV care and by advocating for policies that ensure a comprehensive and humane response to the AIDS pandemic informed by science and social justice.
She also recently joined the AIDS Clinical Trials Group and became the Associate Director of the UW AIDS Clinical Trials Unit in September 2019.
Si is responsible for the management of the clinical, behavioral, and laboratory databases for the research projects conducted by the HOPE group. He is also involved in the management of IRB submissions and renewals to ensure all research projects remain compliant with the human subject research guidelines
Delia Pinto-Santini, PhD, obtained her Molecular and Cellular Biology degree in the laboratory of Dr. Nina Salama, studying the bacterial organism Helicobacter pylori. She is currently the HOPE Project Coordinator and has initiated a research collaboration with Dr. Ann Duerr and Dr. Sam Minot to study microbiome changes associated with HIV outcomes in MSM from Lima, Peru.
Alex Lankowski is a Fellow in the Division of Allergy and Infectious Diseases at the University of Washington. His research seeks to better understand the factors that influence HIV treatment and prevention outcomes in marginalized populations, and to enable the development and implementation of evidence-based interventions to decrease the burden of HIV in such groups. Currently, his work focuses on community-based HIV testing as a potential strategy to reach individuals within high-risk sexual networks in Lima, Peru. Previous work includes research on HIV treatment outcomes in Uganda, supported by a Doris Duke International Clinic Research Fellowship during medical school, and on PrEP uptake in the Bronx, New York during his residency training. He is board certified in Internal Medicine and remains active as a clinician, seeing patients in the outpatient (HIV primary care) and inpatient settings while completing his infectious diseases specialty training.
Michalina Montaño is a postdoctoral trainee on the University of Washington/Fred Hutch Interdisciplinary Training in Cancer Research training grant. Her research interests include HIV-associated health disparities, sexual health, sexual behavior, and HIV and STI prevention. Her postdoctoral research seeks to estimate the burden of untreated HIV among cancer patients in three sub-Saharan African countries (Malawi, Zimbabwe, South Africa) and explore provider-identified barriers to concurrent initiation of cancer and HIV treatment. Her dissertation research focused on the impact of biomedical methods of HIV prevention such as treatment as prevention and pre-exposure prophylaxis on sexual behavior and STI risk among men who have sex with men.
Jess Long is a Post-Doctoral Fellow in the Department of Epidemiology at the University of Washington School of Public Health. Her research focuses on sexual health in vulnerable populations, and particularly behavioral and structural factors that influence disease risk and uptake of prevention and treatment services.
William (Bill) Trebelcock is a HIV Medical Association Medical Scholar and second year medical student at the University of Washington School of Medicine. He is pursuing a career as a board certified Infectious Disease physician specializing in LGBTQ HIV care. Bill is also a volunteer at the UW/Fred Hutchinson Center for AIDS Research and is currently researching HIV Transmitted Drug Resistance at Fred Hutchinson in Seattle
Diana (she/her) is a PhD candidate in the department of Epidemiology at the University of Washington. She received her MPH from the University of Washington and a BA in Mathematics and Economics from Vassar College. Diana’s research includes health disparities among sexual and gender minorities, mathematical modeling of STIs, and HIV phylogenetics. Diana also conducts research with the International Clinical Research Center and Seattle Children’s Gender Clinic.
Deanna Tollefson is a PhD student in Global Health Implementation Science at the University of Washington. After receiving her MPH from Emory University, Deanna worked as an epidemiologist at the US Centers for Disease Control and Prevention (CDC) to strengthen TB surveillance across Africa and Asia and encourage national TB programs to use data for decision-making. In this position, Deanna also served as lead coordinator for CDC’s TB prevention and control projects in China. Deanna is interested in working with global health implementers to design, evaluate, and scale-up evidence-based interventions to improve livelihoods in resource-limited settings.
Yanni Chang is a HIV Medicine Association Medical Student Scholar and fourth-year medical student at the University of Washington School of Medicine. She studied Integrated Biology and Music at the University of California, Berkeley, and has just completed her Master of Public Health degree in the department of Global Health at the University of Washington. Her research seeks to better understand barriers and facilitators of HIV prevention and management uptake among marginalized and underserved communities. For her MPH thesis, she studied characteristics associated with mental health and quality of life outcomes among MSM living with HIV in Peru.
Angela Ulrich, PhD
Trupti Gilada, MD
Carolyn Bain, MPH
Angela Primbas, MD
Anna Greer, MD
Audrey Brezak, MPH
Grace Wandell, MD MPH
Rogelio Valdez, MD-c
Kathy Garcia, MPH
Lindsay Haselden, MD-c